Loading company…
Seoul-based company providing AI solutions for drug discovery, from target identification to preclinical candidates.
Standigm, Inc. provides AI solutions for drug discovery, covering target identification, lead optimization, and preclinical candidate development for pharmaceutical and biotechnology firms. Founded in 2015 in Seoul, South Korea, its founders include Jinhan Kim, Sang Song, and So Yun, with Jinhan Kim also serving as CEO. In July 2021 it raised USD 10 mn in venture funding led by Pavilion Capital. The company has completed six deals since inception and is at the Late stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in